• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配制基础:实施美国药典第797章《药物配制 - 无菌制剂》第14部分:环境质量与控制的注意事项(续)

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued).

作者信息

Okeke Claudia C, Allen Loyd V

机构信息

Claumek PharmaScience, Rockville, Maryland.

出版信息

Int J Pharm Compd. 2009 Jul-Aug;13(4):322-9.

PMID:23966523
Abstract

The design and location of the primary engineering controls within a compounding facility in order to maitain an expected controlled environment is well worth the time and expense involved. If the airflow within the compounding area is not properly designed and maintained, the results can be tragic to not only the compounding personnel but to those patients for whom the preparations are being compounded. Knowledge of the placement of primary engineering controls, air sampling, cleaning and disinfecting, and additional personnel requirements in the area of sterile compounding are essential. Once the guidelines have been studied, compounding personnel should apply practicality and common sense to avoid problems with compounded sterile preparations.

摘要

为维持预期的受控环境,在配制设施内设置主要工程控制措施的设计和位置,所涉及的时间和费用是非常值得的。如果配制区域内的气流设计和维护不当,不仅对配制人员,而且对接受配制制剂的患者而言,后果都可能是灾难性的。了解主要工程控制措施的放置位置、空气采样、清洁和消毒以及无菌配制区域的其他人员要求至关重要。一旦研究了这些指南,配制人员应运用实际经验和常识来避免无菌配制制剂出现问题。

相似文献

1
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued).配制基础:实施美国药典第797章《药物配制 - 无菌制剂》第14部分:环境质量与控制的注意事项(续)
Int J Pharm Compd. 2009 Jul-Aug;13(4):322-9.
2
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第15部分:人员培训、清洁与着装
Int J Pharm Compd. 2009 Sep-Oct;11(5):420-6.
3
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第8部分:稳定性和使用期限
Int J Pharm Compd. 2008 Jul-Aug;12(4):344-53.
4
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第4部分:消毒剂和防腐剂选择与使用的注意事项
Int J Pharm Compd. 2007 Nov-Dec;11(6):492-9.
5
Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13.配制基础;实施美国药典第797章《药物配制-无菌制剂》第13部分的注意事项。
Int J Pharm Compd. 2009 May-Jun;13(3):234-8.
6
Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.配制基础:配制人员在实施《美国药典》第797章药物配制——无菌制剂第2部分中的职责。
Int J Pharm Compd. 2007 Jul-Aug;11(4):313-23.
7
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.配制基础:实施美国药典第797章药物配制-无菌制剂的考虑因素,第7部分:微生物污染风险水平、12小时使用和立即使用。
Int J Pharm Compd. 2008 May-Jun;12(3):252-7.
8
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: suggested standard operating procedures.
Int J Pharm Compd. 2009 Nov-Dec;13(6):546-53.
9
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.配制基础:实施美国药典第797章无菌药物制剂配制的注意事项,第6部分:2008年对第797章的修订
Int J Pharm Compd. 2008 Mar-Apr;12(2):136-44.
10
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.实施美国药典第797章——药物配制-无菌制剂,第5部分:配制制剂的准确性、无菌性和灭菌验证的注意事项。
Int J Pharm Compd. 2008 Jan-Feb;12(1):54-60.

引用本文的文献

1
Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data.职业环境中抗肿瘤药物的暴露:生物监测数据的系统评价。
Int J Environ Res Public Health. 2022 Mar 21;19(6):3737. doi: 10.3390/ijerph19063737.